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Angiotensin II and catecholamines interaction in short-term low protein
feeding. Renal and systemic hemodynamic responses to an a-adrenergic
agonist (norepinephrine, NE) and an a-adrenergic antagonist (phentol-
amine, PHEN) were studied in weanling rats pair-fed isocaloric diets
containing either normal (NP, 23%) or low (LP, 6%) protein. Mean
arterial pressure (MAP) rose less with NE and fell more with PHEN in
LP than in NP. Plasma NE and epinephrine (E; 46 5 and 51 4ng/ml)
were higher in LP than in NP (26 3 and 39 3ng/ml). These could not
be attributed to changes in red cell mass nor the volumes of plasma,
extracellular, or interstitial fluid in LP versus NP. Plasma angiotensin II
(Ang II), renin (PRA), and aldosterone (PA) were lower in LP than in
NP. An increased number without changes in affinity of glomerular Ang
II receptors was found in LP compared to NP, while a1- and a2-
adrenergic receptors were down-regulated in LP as compared to NP
without changes in affinity for the a1 receptor but with an increase in
renal a2 receptor affinity. LP (vs. NP) decreased GFR and RPF, and
increased renal vascular resistance (RVR). NE decreased RPF equally
in NP versus LP but raised RVR approximately twofold in NP versus
LP. PHEN decreased RPF and increased RVR less in LP than in NP.
Moreover, PHEN increased renal renin content approximately seven-
fold over the basal NP values. Exogenous Ang II increased RVR and
lowered RPF more in LP than in NP. Enalapril abolished all the
hemodynamic changes of LP and restored the systemic response to NE.
These findings are evidence that short periods of protein deprivation
lead to systemic and local (intrarenal) alterations in adrenergic state and
the renin-angiotensin system, and that these two are principally respon-
sible for the adaptive hemodynamic changes observed. Dietary protein
plays a significant role in the hormonal regulation of intrarenal hemo-
dynamics.
Alterations in dietary protein intake have been shown to
affect mean arterial pressure in humans [1, 2] and experimental
animals [3—5]. In the rat, calorie-protein deprivation causes a
significant decrease in mean arterial pressure (MAP) [3, 4].
Similar observations have been made in chronically malnour-
ished subjects [6]. Experimental evidence also indicates that
severe protein deprivation is associated with a decrease in
cardiac output and cardiac work [1, 6]. Nevertheless, a system-
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atic, detailed study of the effects of dietary protein on BP
regulation has not been performed.
Studies by Sonkodi et al [7] showed a decrease in plasma
renin (PRA) and blood pressure (BP), and a decrease in the
pressure response to exogenous angiotensin II (Ang II) in rats
maintained on a protein-free diet for 14 days as compared to
animals ingesting normal protein. However, since these animals
were not pair-fed and their diets were not isocaloric, it is
difficult to assess if the hemodynamic alterations were caused
by the protein deficiency per se and/or by the differences in
caloric intake. Studies in our laboratory have shown that two
weeks of protein deprivation in pair-fed rats results in a
significant decrease in PRA and significant increase in renal
renin content (RRC) [8]. Identical findings were reported by
Kapoor and Krishna [9] in the rat, and—in relation to similar
changes in PRA—in humans by Paller and Hostetter [10].
Severe restriction of protein intake has also been shown to
decrease plasma volume (PV) [11], but the relationship between
these changes and alterations in BP remains unknown.
Recent studies have shown that the sympathetic nervous
system activity, estimated by the measurement of norepineph-
rine (NE) turnover in heart and interscapular brown adipose
tissue, is increased in low protein fed (LP) rats [12]. Those
studies, however, did not establish whether dietary protein can
result in alterations in the sympathetic (noradrenergic) control
of BP or in renal hemodynamics.
Short-term LP feeding in the rat is associated with propor-
tional reductions in GFR and renal perfusion flow (RPF) so that
the filtration fraction (FF) remains relatively constant [13].
Studies in Munich-Wistar rats fed LP diets for six months have
shown a reduction in single nephron GFR (SNGFR) propor-
tional to the fall in overall GFR. The decrease in GFR appears
to be the direct result of increased pre- and postglomerular
resistances, as well as a decrease in the glomerular ultrafiltra-
tion coefficient [13], changes similar to those induced by Ang II
administration [14]. Studies in our laboratory have provided
evidence that intrarenal Ang II is, at least partly, responsible for
the reduced GFR and RPF induced by short-term protein
deprivation [8].
The present study examined the role of the renin-angiotensin
system (RAS) and sympathetic nervous system and their inter-
relationship in affecting BP regulation and renal hemodynamics
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in rats on short-term dietary protein reduction. This is particu-
larly relevant in view of the suggestion that LP diets may be
beneficial in the prevention or amelioration of chronic renal
failure through effects on glomerular hemodynamics [15]. More-
over, these studies may provide insight into the mechanisms of
renal and systemic hemodynamic adaptation to protein malnu-
trition in humans.
Methods
Experimental animals and dietary regimen
Studies were performed in 104 male Wistar-Furth rats (Na-
tional Cancer Institute, Fort Detrick, Maryland, USA) weighing
90 lOg. Rats were fed a normal protein (NP) diet (23% casein,
ICN Nutritional Biochemicals, Cleveland, Ohio, USA) with a
normal sodium (0,5%) and potassium (1.3%) content, and
allowed free access to food and water for one week. After this
equilibration period, rats were divided into two subgroups and
pair-fed isocaloric normal sodium diets containing LP or NP for
two weeks. NP rats were pair-fed according to the protein-
deficient rats by feeding them a quantity of the control diet
equal to the amount eaten by the LP rats during the preceding
24 hours. Details on the composition of the experimental diets
have been published previously [8]. Animal experimentation
was conducted in accordance with the NIH Guide for the Care
and Use of Laboratory Animals.
Balance studies
Twenty-four rats were placed in individual metabolism cages
and subjected to the dietary regimens described above. A
four-day metabolic study was carried out during week 2 of
protein deprivation in both NP (N = 12) and LP (N = 12) rats.
Studies consisted of daily measurements of body weight, food
and water intake and urine volume, osmolality, sodium, potas-
sium, and urea concentration. At the end of the study, blood
samples for the determination of plasma electrolyte, protein and
urea, aldosterone concentration, PRA, and NE and epinephrine
(E) concentrations, were obtained using chronic catheters [16].
Rats were anesthetized with light ether administration and,
through an incision on the ventral surface of the neck, the
carotid artery was cannulated with a polyethylene tube (PE-50)
filled with heparinized saline. The tubing was led subcutane-
ously to emerge at the base of the neck and threaded through a
thin wire spring to avoid displacement. After surgery, the
animals were housed in individual cages and the tubings were
passed through the top of the cage to be connected to 1 ml
plastic syringes with 21-gauge hypodermic needles. Arterial
blood samples (0.8 ml) were obtained four to five hours later
while rats were awake, unrestrained, and undisturbed.
Erythrocyte and volume studies
Twelve male Wistar-Furth rats fed LP (N 6) or NP (N =6)
diets for two weeks were used in these studies. The rats were
anesthetized with sodium pentobarbital (20 mg/kg body wt,
i.p.), and catheters (PE-50) were inserted into the left femoral
vein for infusion and into the right carotid artery for blood
collection. Each rat was also bilaterally nephrectomized by
ligation of the renal pedicles to prevent renal excretion of the
radioisotope. Sixty minutes later, the tracers 3H-methoxy inulin
(50 MCi), 125R1SA (5 jsCi), and 51Cr-RBC (10 MCi) were injected
into the femoral vein and I ml blood samples of arterial blood
were collected every 10 minutes for a 30 minute period.
Hematocrit was determined by the method of Sterling and Gray
[17] using 51Cr-RBC harvested from donor rats. PV was mea-
sured by a modification of the technique of Crispell, Porter and
Nieset [18] using 125 labeled serum albumin. Total extracellular
fluid volume (ECFV) was determined by the rapid equilibration
of 3H-methoxy inulin [19]. Interstitial fluid volume (ISFV) was
calculated from the difference between ECFV and PV.
NE-induced pressor response
Twelve male rats were fed NP (N = 6) or LP (N = 6) diets.
Rats were lightly anesthetized with sodium pentobarbital (20
mg/kg body wt, i.p.), and catheters (PE =50)were inserted into
the left femoral vein for administration of drugs and into the
right carotid artery for MAP monitoring. MAP was monitored
with an electronic transducer (Statham Instruments, Hato Rey,
Puerto Rico) connected to a direct writing recorder (model
775A, Hewlett-Packard Co., Palo Alto, California, USA). The
rats were then placed in restraining cages (Narco Biosystems,
Inc., Houston, Texas, USA) and allowed to awaken. Experi-
ments were performed at least two to three hours after comple-
tion of surgery. After this equilibration period, basal MAP was
monitored continuously. A bolus (all doses are given in the
corresponding tables) of NE (Levophed, Wintrhop-Breon Lab-
oratories, New York, USA) was administered intravenously
(i.v.), allowing 15 minutes between the injection of the various
doses.
Angiotensin-induced pressor response
Twelve male rats were subjected to the identical dietary
regimen described above. Two weeks after LP feeding, control
(N = 6) and protein-deficient (N = 6) rats were prepared for
Ang II injection as described already for NE injection. After
recovery from anesthesia, basal MAP was determined contin-
uously. The various doses of Ang II (Va15-A II, Sigma Chemical
Co., St. Louis, Missouri, USA) were given i.v., and 15 minute
intervals were observed between injections.
To further determine the contribution of the a-adrenergic
system to BP regulation in LP, 30 mm after evaluation of the
response to Ang II, each rat received a bolus of 100 pg/l00 g
body wt of the a-adrenergic blocker (Phentolamine, Regitine,
CIBA, Summit, New Jersey). In preliminary studies, this does
of phentolamine resulted in 74 5% inhibition of the pressor
response induced by 0.3 g/l00 g body wt of NE (Levophed).
BP was monitored throughout the experiment. Fifteen minutes
later, when baseline MAP was constant, the pressor response to
a bolus injection of Ang 11(0.1 g/100 g body wt) was evaluated
again.
Clearance studies
Clearance studies were performed before and after the ad-
ministration of NE, Ang II, and phentolamine in awake rats fed
LP (N = 18) or NP (N = 18) diets. Rats were lightly anesthe-
tized with ether to insert polyethylene catheters in a femoral
vein for i.v. infusions and in the left carotid artery for measure-
ments of arterial blood pressure (ABP) and blood sampling. The
bladder was also cannulated through a small suprapubic inci-
sion. During surgery the rats were infused with isotonic saline
containing inulin (6 mg/ml) and PAH (0.1 mg/ml) at a rate of 0.03
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mllmin. ABP was monitored as described. The rats were
allowed to recover from ether anesthesia for two hours. After
this equilibration period, two 20-minute clearance determina-
tions were made in each animal before and after administration
of the drug. NE (30 ng/min/l00 g body wt) and Ang 11(10
ng/min/100 g body wt) were given at constant infusion during
the clearance measurements. Clearance periods started after an
equilibration period of 15 minutes. Regitine and enalapril were
given as a bolus (100 .tg/l00 g body wt) and clearance studies
were repeated after an additional 15-minute equilibration pe-
riod. Blood samples (0.3 ml) were obtained at the midpoint of
each 20-minute period thereafter. Blood volume was restored
after sampling with blood donated from LP or NP rats for the
stipulated length of the experiment (2 weeks).
GFR and RPF were determined from the clearance of inulin
and PAH, respectively. The GFR/RPF ratio equates the FF.
Renal vascular resistance (RVR) was calculated as:
RVR = (ABP - RVP)/RBF
where RVP = renal venous pressure = 3 mm Hg, RBF =
RPFI(1 — Hct). The value for RVP was based on measurements
in NP (3.1 0.3 mm Hg, N = 4) and LP (2.9 0.4mm Hg, N
= 5) rats. These values did not change after the administration
of Ang II which caused the greatest increase in intrarenal
resistance (NP = 2.9 0.2, N = 3; LP 3.0 0.3, N = 3).
Therefore, RVP was assumed not to change under any of the
other experimental conditions.
Analytical methods
Sodium and potassium concentrations in plasma and urine
were measured by flame photometry (Beckman, KLiNa,
Flamephotometer), and osmolality by vapor pressure osmom-
etry (Wescor, Model 5130). Plasma and urine urea concentra-
tion were measured colorimetrically using the method of Na-
telson and Natelson [20]. Plasma total protein concentration
was measured by a modification of Lowry's method [21] using
bovine serum albumin as standard.
PRA and RRC were measured according to Orth et al [22] by
determination of the amount of Ang I generated during one hour
of incubation at 37°C with inhibitors of converting enzyme and
angiotensinases. Ang I concentration was measured by radio-
immunoassay (New England Nuclear Corp., Boston, Massa-
chusetts, USA). '251-Ang I was counted in a Model 110 Picker
refrigerated fJIy counter. Values for PRA are expressed as ng
Ang I/ml/hr while values for RRC are expressed as ng Ang I/mg
protein. Details for the handling of tissue and the conditions of
the assay for measurement of RRC have been presented from
this laboratory before [8]. Plasma aldosterone concentration
was measured by direct radioimmunoassay [23] (Abbott Labo-
ratories, North Chicago, Illinois, USA). Values are expressed
as ng%. Plasma NE and E concentrations were measured in
duplicate by the radioenzymatic methods [24]. Radioactive
materials were purchased from New England Nuclear. The
sensitivity of this method has been reported as 1 pg for NE and
E [16].
Glomerular receptor binding assays
In another set of experiments, two groups (6 LP and 6 NP in
each) were studied at different times. A total of eighteen rats of
the two pair-fed groups were sacrificed by decapitation at the
end of 14 days. The kidneys were immediately excised, bi-
sected, and immersed in ice-cold modified Tris-EDTA buffer
(50 mM Tris-HC1, EGTA, pH 7.4). Glomeruli were separated by
sieving techniques as previously described [25]. Glomeruli were
used intact for Ang II receptor analysis, while crude glomerular
membranes were prepared for a1- and a2-adrenergic receptor
binding studies.
Isolated glomeruli were homogenized by polytron at a setting
of 50 for three 15-second bursts and at a setting of 90 for 20
seconds twice, after which they were centrifuged at 4°C for 20
minutes at 48,000 g as described by Sundaresan and coworkers
[26].
['251]Ang II was used to assess the Ang II receptor, while
[3H]prazosin and [3H]rauwolscine were used to assess a1- and
a2-adrenergic receptors in glomerular plasma membrane frac-
tions. Membranes were used fresh or stored at —70°C until use.
Storage of membranes up to two weeks does not change the
results appreciably [27].
In all radioligand binding assays, the Tris buffer was used at
pH 7.2. Rauwolscine was always contained in dark tubes to
protect it from light. Reactions were terminated by pouring the
incubation medium onto membranes. Membranes were col-
lected on 0.1% polyethylenamine pretreated Whatman GF/C
microfiber glass filters by rapid vacuum filtration, followed by
four washes with 20 ml ice-cold buffer. Filter drying and
handling were as described before by McElroy and Zimmerman
[27].
Specific binding for radioactive prazosin and rauwolscine was
defined as the radioactivity displaced by 10 pii phentolamine
and comprised 80 to 95% of total bound counts at a concentra-
tion of these radioligands near their dissociation constant (Kd)
values. Cold Ang II in concentrations three orders of magnitude
greater than the labeled compound were used for assessment of
specific binding.
Protein content of membrane preparations was measured by
the method of Lowry [28].
Statistical methods
The PROPHET system was used for data storage, statistical
analyses, and graphics. Statistical analyses were done using
standard programs contained in PROPHET. Groups were com-
pared using Student's i-test, while comparison within groups
was done by paired-i analysis. Nonparametric methods (Mann,
Whitney, and Wilcoxon rank sum tests) were used as appropri-
ate. A P value of <0.05 was considered significant. Analysis of
the saturation binding curves was conducted by the method of
Scatchard using the ligand program of Munson and Rodbard
[29].
Results
Metabolic studies
After two weeks on LP diets, rats weighed less than control
pair-fed rats (Table 1). Urine flow rate was lower in LP rats
despite an intake of water similar to NP rats. Since rats were
pair-fed, food intake corrected for body weight was significantly
higher in the protein-deficient group (NP 6.6 0.5, LP 7.6 0.8
g/24 hr/lOO g body wt, P < 0.05). Protein deprivation, as
expected, significantly decreased urine osmolality and urine
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NP(N = 12) LP(N = 12)
Body wt g 173.0 5.0 134.0 3.Oa
V ml/24 hr/100 g body wt 18.0 1.0 12.0 1.Oa
H20, mi/24 hr/100 g body wt 23.0 4.0 21.0 6.0
1>Na mEqiliter 146.0 1.0 147.0 1.0
K mEq/iiter 3.8 0.1 4.0 0.2
Pureu mg% 15.2 0.4 3.8 0.3
'prot ing% 7.1 0.1 6.7 0.la
ilb mg% 4.4 0.1 4.1 0.la
Table 2. Effects of LP on PRA and plasma aldosterone (PA)
concentration
NP (N = 12) LP (N 12)
Basal Week 2 Basal Week 2
PRA ng Al/mi/hr 6.9 0.4 7.0 0.7 7.5 0.7 4.6 09a,b
A ng/100 ml 7.0 0.5 7.7 0.7 7.7 0.9 3.4
NP(N =6) LP(N=6)
NE ng/ml 26 3 46 5
E ng/,n! 39 3 51 4
urea excretion. Urine sodium and potassium excretion were not
different between groups (data not shown). Plasma sodium and
potassium concentrations were not different in LP versus NP
rats. However, plasma urea and plasma protein concentrations
were significantly diminished in the LP group.
PRA and PA concentrations
PRA did not change in the NP rats two weeks after basal
determinations (Table 2). Basal PRA in the LP group was not
different from the NP group. In contrast, PRA was significantly
diminished in the protein-deficient rats two weeks after dietary
changes. Changes in plasma aldosterone paralleled the changes
in PRA; it was significantly lower in LP than in NP rats at the
end of the experimental period.
PNE and PE concentrations
Both plasma NE (NP 26 3 vs. LP 46 5 ng/ml, P < 0.05)
and E (NP 39 3 vs. LP 51 4 ng!ml, P < 0.05) concentrations
were found to be significantly higher in rats fed LP for two
weeks (Table 3).
Determination of PV, red cell mass, total blood volume,
extracellular and interstitial fluid
Table 4 summarizes values for erythrocyte and plasma vol-
umes measured in LP (N = 6) and NP (N = 6) for two weeks.
NP(N=6) LP(N=6)
Body wt g 176.0 5.0 147.0 5.Oa
HCT % 41.0 1.0 42.0 1.0
PV 3.6 0.2 3.8 0.1
TBV 6.0 0.2 6.4 0.1
RCV 2.4 0.1 2.6 0.1
RCV/TBV 39.0 1.0 41.0 2.0
ECFV rni/100 g body wt 16.3 0.5 16.7 0.4
IFV mi/100 g body wt 12.6 0.3 12.9 0.2
10
0.0 0.1 0.2 0.3 0.4 0.5
NE, ,.tg/100 9/body wt
Fig. 1. Effect of LP diet on MAP (mm Hg) response to NE. Basal MAP
did not differ between the two groups (U, NP = 116 2;, LP = 109
4). All results are mean SE. Each symbol represents the mean of 6
rats and 3 determinations of BP. The values for MAP are the absolute
change from the baseline. There was a 15 minute interval between
doses. While a "line" connects the points, each MAP change was
observed after BP had returned to normal following each dose.
When corrected for body weight, none of the volume variables
were significantly different between LP and NP rats. Changes in
vascular permeability to tracer albumin can be ruled out since
the ratio of RCV/BV almost equaled hematocrit values.
Pressor response to exogenous NE in NP and LP rats
The effects of protein deprivation on the pressor response to
NE are illustrated in Figure 1. No significant difference in basal
MAP was observed between NP and LP rats (NP 116 2, LP
109 4 mm Hg). Exogenous administration of NE significantly
increased MAP in both NP (116 2 vs. 174 2 mm Hg, P <
0.01) and LP (109 4 vs. 153 2 mm Hg, P < 0.01) rats. MAP
after NE administration, however, was significantly lower in
the protein-deficient than in the normal rats, following injection
of 0.01, 0.1, 0.3, and 0.4 g of NE. Thus, the magnitude of the
pressor response to NE was significantly diminished by protein
deprivation.
To further assess the contribution of the adrenergic system in
the regulation of BP and its interaction with Ang II, the pressor
response to exogenous Ang II was examined after the admin-
istration of the nonspecific a-adrenergic blocker, phentolamine,
Table 1. Results of two weeks of NP and LP Table 4. Effects of LP on erythrocyte and plasma volumes
Abbreviations are: body wt, body weight; V, urine flow rate; H201,
water intake; Na and P10 plasma sodium and potassium; oroa, 'prot
and plasma urea protein and albumin concentration. Values are
mean SEM.
ap< 0.05
Abbreviations are: body wt, body weight; HCT, hematocrit; PV,
plasma volume; TBV, total blood volume; RCV, red cell volume;
ECFV, extracellular fluid volume; IFV, interstitial fluid volume. Values
are mean SEM.
a NP vs. LP, P < 0.05
60
50
40
4)0)30
(.)
20
Values are mean SEM.
a NP vs. LP, P < 0.05
b Significantly different from basal values in the same group, P < 0.05
Table 3. Effects of two weeks of LP on NE and P concentration
Values are mean SEM.
a NP vs. LP, P < 0.05
200
150
C
50
Basal PHEN All + PHEN Basal ENAL NE + ENAL
50
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Fig. 2. Interaction of adrenergic state and Ang II in LP. Symbols are:
(LI) NP, N = 6; (ia) LP, N = 6. Results are mean SE. Phentolamine
100 g/100 g body wt reduced MAP to a significantly greater degree in
LP rats. Administration of Ang 11(0.1 pg/kg body wt) raised MAP (mm
Hg) to identical absolute values in NP and LP. Nevertheless, the
absolute change in LP (+88 5 mm Hg) was significantly greater than
in NP (+69 7 mm Hg), P < 0.05.
in LP and NP rats. A significant decrease in basal MAP was
observed after phentolamine in the NP (121 4 vs. 103 3 mm
Hg, P <0.05) and the LP(lll 6 vs. 81 3mm Hg, P <0.05)
groups. The decrease in MAP, however, was significantly
greater in the protein-deficient than in the normal group.
Administration of Ang II after phentolamine was followed by an
increase in MAP in both NP and LP rats (Fig. 2). The increase
in MAP was significantly greater in the LP (+88 5 mm Hg)
than in the NP (±69 7 mm Hg, P < 0.05) rats. Finally, as
shown in Figure 3, the converting enzyme inhibitor enalapril
equalized the effect of exogenous NE in NP and LP.
Assessment of renal hemodynamics before and after
exogenous administration of NE, Ang II, phentolamine, and
enalapril in LP and NP rats
In the four groups of animals studied (Tables 5 to 8), LP was
associated with a significant decrease in GFR and RPF and a
significant increase in RVR. In addition, no significant changes
in MAP and FF were detected between NP and LP rats.
Exogenous administration of NE (Table 5) to normal rats
resulted in a significant increase in MAP, FF, and RVR, a
decrease in RPF and RVR, and no significant change in GFR. In
the LP rat, NE administration also significantly increased MAP,
FF, and RVR. A significant reduction in both GFR and RPF
was observed in this group. It should be noticed that NE
administration further reduced GFR and RPF in LP rats. In this
setting, NE increased RVR dramatically (twice as much as in
NP rats). While FF also rose, it was no different from the rise in
NP rats. Exogenous administration of Ang II (Table 6) signifi-
cantly raised MAP, RVR, and FF in both NP and LP rats.
Regardless of protein intake, Ang II administration significantly
decreased RPF but did not change GFR. Ang II administration
to LP rats increased RVR dramatically. RPF fell 45%; despite
this, GFR did not change while FF rose sharply after Ang II.
Fig. 3. Interaction of NE andAng II in LP and NP. Symbols are: (El)
NP,N = 6; (Ii) LP, N = 6. Results are mean sE. Enalaprilwas given
i.v. as a bolus (100 g/l00 g body wt). NE was also administered as a
bolus (0.3 g/l00 g body wt) 20 minutes after BP was constant.
Table 5. Renal hemodynamics before and after exogenous NE (30
ng/minIlOO g body wt) administration in NP and LP rats
NP(N= 6) LP(N= 6)
-NE +NE -NE +NE
MAP 120.0 3.0 142.0 4.0" 132.0 5.0 140.0 4.0"
mm Hg
GFR 1.36 0.22 1.29 0.11 0.83 0.13a 0.69 008a.b
mi/mm
RPF 8.5 0.6 4.7 02b 4.0 Ø7 2.2 03a.b
mi/mm
FF % 0.17 0.02 0.34 0.04" 0.20 0.02 0.32
RVR 7.0 1.0 15.0 1.0" 19.0 3Ø 32.0
Values are mean 5EM. Total duration of NE infusion was 40 mm.
a NP vs. LP, P < 0.05b +NE vs.
-NE, P < 0.05
These results indicate an increase in afferent and efferent
arteriolar resistance, but predominantly the latter.
Administration of the a-adrenergic blocker phentolamine
(Table 7) did not alter MAP or GFR in NP rats but significantly
diminished both variables in the LP group. A decrease in RPF
and an increase in RVR were detected in the NP and LP groups.
After phentolamine administration, FF increased regardless of
protein intake. Phentolamine administration significantly re-
duced MAP in the LP rats, while it had no effect on this variable
in the NP group.
Administration of the converting enzyme inhibitor enalapril
(Table 8) did not alter renal function in normal rats. As
previously observed with captopril [8], enalapril restored GFR,
RPF, and RVR to normal values in LP rats. Enalapril adminis-
tration did not affect MAP in the LP rats.
Effect of phentolamine administration on PRA and RRC in
NP and LP rats
As shown in Table 9, phentolamine administration signifi-
cantly increased PRA and RRC in NP and LP rats. It should be
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Table 6. Renal hemodynamics before and after exogenous Ang 11(10
ngIminhlOO g body wt) administration in NP and LP rats
NP(N=6) LP(N =6)
—Ang II +Ang II —Ang II +Ang II
MAP
mm Hg
GFR
mi/mm
RPF
mi/mm
FF %
RVR
132.0 7.0
1.85 0.12
9.4 1.4
0.21 0.02
9.0 2.0
165.0 4.0"
1.76 0.13
5•7 03b
0.31 0.03"
19.0 1.0"
133.0 5.0
0,86 0ll.b
3.1 0.28
0.26 0.03
20.0 1.08
168.0 4.0"
0.78 o.o6a
1.7 02a,b
0.47 0.05"
46.0 5.0a.I
Values are mean SEM. Total duration of Ang II infusion was 40 mm.
a NP vs. LP, P < 0.05
b
+Ang II vs. —Ang II, P < 0.05
Table 7. Renal hemodynamics before and after exogenous
phentolamine (100 sg/min/l00 g body wt as bolus) administration in
NP and LP rats
NP(N=6) LP(N=6)
—Phen +Phen —Phen +Phen
MAP 123.0 3.0 120.0 3.0" 128.0 5.0 113.0 4.01
mm Hg
GFR 1.40 0.10 1.32 0.09 0.81 0.048 0.62 014a.b
mi/mm
RPF 7,9 0.4 5.0 0.6" 3,4 0.2 2.5 03a,b
mi/mm
FF % 0.19 0.02 0.27 0.06" 0.24 0.03 0.28 0.01"
RVR 8.0 1.0 12.0 2.0" 18.0 1.oa 24.0
Values are mean SEM. Two clearances (20 mm) were obtained after
Phen administration.
a NP LP, P < 0.05
b +Phen vs. —Phen, P < 0.05
Table 8. Renal hemodynamics before and after exogenous enalapril
(100 g/min/100 g body wt) administration in NP and LP rats
NP(N =6) LP(N =6)
—Enal +Enal —Enal +Enal
MAP 119.0 4.0 117.0 3.0 122.0 3.0 118.0 4.0
mm Hg
GFR 1.58 0.09 1.50 0.08 0.83 0.02k 1.33 0.12"
mi/mm
RPF 7.8 0.3 7.6 0.3 3.8 0.38 6.8 0.8"
mi/mm
FF % 0.20 0.03 0.20 0.04 0.22 0.02 0.20 —0.04
RVR 8.0 1.0 7.0 2.0 18.0 1.08 8.0 2.0"
Values are mean SEM. Enalapril was given as a bolus.
NP vs. LP, P < 0.05
b +Enal vs. —Enal, P < 0.05
noted, however, that the increase in PRA was significantly
greater in NP rats (+ 14 5 ng Ang I/mllhr) than in the LP (+7.7
0.3 ng Ang I/ml/hr, P < 0.05). In contrast, the increase in
RRC was significantly greater in the LP (+ 11,468 736 ng Ang
I/mg protein) than in the NP (+4,445 123 ng Ang I/mg protein,
P < 0.05) group. After phentolamine administration, PRA
remained significantly lower and RRC significantly higher in LP
rats.
Table 9. Effects of phentolamine (Phen; 100 g/100 g body wt) on
PRA and RRC in NP and LP rats
NP(N= 12) LP(N= 12)
Basal Phen Basal Phen
PRA ng 7.3 0.8 21.3 3.5k' 4.8 0.58 12.5 45a.b
Al/mi/hr
RRC ng/ 2587 273 7032 654" 5725 479k 17193 1527a.b
mg prof
Values are mean SEM. Phentolamine was given as a bolus.
a NP vs. LP, P < 0.05
"Significantly different from basal values in the same group, P < 0.05
Table 10. Affinity Kd and receptor number Bmax in glomerular
plasma membranes of glomeruli isolated from low (LP) and normal
(NP) protein-fed rats
Affinity
NP
Kd nM
LP
Receptor number
Bmax fmol/mg
NP LP
'251-Ang II 1.22 0.22 1.11 0.22 432 75 763 89
13H]-prazosin 0.059 0.001 0.058 0.001 46 4 17 2
[3H]-rauwolscine 0.62 0.03 0.31 0.098 84 6 32 4
Values are mean SD; N = 6 for each group.
°P < 0.001
Glomerular receptor binding assays
Table 10 shows the results of a1- and a2-adrenergic and Ang
II binding studies. There were no significant changes in the
affinity values (Kd) for two of the three ligands used (Ang II,
[3H1-prazosin), while the Kd for [3H]-rauwolscine was signifi-
cantly diminished in the LP group. In contrast, the number of
receptors, as assessed by Bmax, was higher for Ang II in LP
compared to NP and lower in LP, for both a1- and a2-adrenergic
receptors. These results are compatible with the low plasma
renin and Ang II levels in LP compared to NP and with the
higher levels of catecholamines in LP compared to NP shown in
the present studies.
Discussion
These studies corroborate previous reports from this and
other laboratories [8, 9, 13] of a decreased RPF and GFR in rats
fed LP (6%) diet for two weeks as compared to NP (23%) rats.
In addition, our data show that short-term LP feeding results in
a hyperadrenergic state as evidenced by increased circulating
plasma concentrations of E and NE (Table 3) coupled to a
greater response to the hypotensive effects of i.v. phentolamine
administration. Furthermore, the BP response to exogenous
NE was blunted (Fig. 1) in LP as compared to NP, suggesting
down-regulation of a-adrenoreceptors in peripheral resistance
vessels [30]. These results are strong evidence that BP regula-
tion in LP is primarily dependent on the neuroadrenergic
system. Studies of isolated glomerular membranes revealed
down-regulation of both a1- and a2-adrenergic receptors in LP
as compared to NP. Inasmuch as these are a reflection of the
intrarenal vasculature, our studies reveal that a renal and
systemic hyperadrenergic state results from short-term protein
deprivation.
The increase in circulating catecholamines was not the result
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of alterations in total blood or plasma volume, extracellular
fluid or interstitial fluid volume (Table 4), which were un-
changed despite a modest but significant reduction in plasma
protein concentration (Table 1). It should be noted that, while
the reduction in plasma albumin was significant, it did not
represent hypoalbuminemia as expected in cases of overt
protein malnutrition. Increased sympathetic nervous system
activity has been described in rats fed LP for longer periods
[12], but the effects of this change on renal function and the
RAS had remained until now largely unexplored.
Phentolamine administration led to a rise in PRA that was
almost twice the level in NP than in LP rats (Table 8).
Furthermore, this was attended by a dramatic rise in RRC in LP
rats to a value almost three times the change observed in NP
and almost sevenfold that of basal renin content in NP kidneys.
Before phentolamine administration, LP rats had a mean PRA
that represented only 66% of that in NP, while RRC was almost
twice in LP than in NP. These results indicate that a defect in
renin secretion existed in LP that was partially corrected by
phentolamine. Since phentolamine increased PRA—a good
index of renin secretion—in LP as well as NP rats, it is evident
that partially defective secretion persisted after a blockade, but
that enhanced a-adrenergic activity contributed to diminished
basal renin secretion. a2 Agonists are known to inhibit renin
secretion by coupling to an inhibitory G protein (G1) which
decreases cAMP formation and increases intracellular calcium
in the granular cells [31]. The demonstration that a-adrenergic
receptor down-regulation was present in glomerular membranes
suggests that a similar situation existed in the renin-containing
cells of the afferent arteriole and possibly the mesangium.
Although we cannot explain from our data why there is an
increase in the affinity for the renal a2 receptors, it is tempting
to speculate that such cellular adaptation may facilitate the
inhibition of renin release in LP and protect the kidney from
severe Ang II mediated vasoconstriction.
Low PRA and basal Ang II levels, previously described in
LP, were corroborated by the present studies [9]. Thus, it was
not surprising that the number, but not the affinity, of glomer-
ular Ang II receptors was increased in LP as compared to NP.
Moreover, this explains why exogenous administration of Ang
II led to a greater increase in RVR and a greater fall in RPF in
LP than NP.
On the other hand, we were surprised by the fact that, as
might be expected from the reduced plasma Ang II levels and
receptor up-regulation, systemic blood pressure response to
Ang II was not greater in LP than in NP, as has been shown
under other circumstances of variations in in vivo changes in
receptor occupancy [32, 33]. Contrary to what we expected in
view of low plasma Ang II levels and, presumably, receptor
up-regulation [32, 33], the blood pressure response to exoge-
nous Ang II was not different between LP and NP. This
indicates that the response of the peripheral vasculature to Ang
II was different from that of the renal circulation, and that
dietary protein modulates the receptor for Ang II differentially.
Further support for this suggestion is the fact that Ang II also
led to identical changes in blood pressure even after a blockade
(Fig. 2). These experiments do not permit an analysis of the
explanation as to why LP changes the systemic but not the renal
response to Ang II. Nevertheless, the finding that inhibition of
Ang II formation by enalapril equalized the increase in BP
response to exogenous NE (Fig. 3) suggests that the higher Ang
II levels in NP mediated the greater basal hypertensive effect of
NE in this group (Fig. 1). The fact that Ang II and NE may
modify each other's interactions with their respective receptors
has been pointed out by others [33—35].
Strong evidence of an intrarenal interaction of NE and Ang II
to modulate glomerular hemodynamics in the normal rat has
also been advanced by several studies [36—38]. That this is also
the case in LP rats can also be gathered from the experiments in
Tables 5 to 7. In NP rats, exogenous administration of NE or
Ang II and phentolamine (nonspecific a blocker) reduced renal
blood flow by increasing renal resistance, yet GFR remained
unchanged. Since both NE and Ang II reduce the ultrafiltration
coefficient [36], the filtration rate must have remained normal
despite afferent arteriolar vasoconstriction as a consequence of
a marked increase in efferent arteriolar resistance. That this in
fact was the case can be deduced from the marked increases in
FF and RVR in NP animals receiving NE, PHEN, and Ang II
(Tables 5 to 7). The important afferent and efferent arteriolar
vasoconstrictor effects of NE and Ang II, respectively, are well
known [35].
In contrast to NP, the response of LP to NE, PHEN, and Ang
II included further reductions in GFR and RPF, and significant
increases in RVR and FF. Although the effects of Ang II and
NE might be from interactions with their respective intrarenal
receptors [35, 361, the further vasoconstriction induced by
PHEN is evidence that local Ang II was responsible, particu-
larly in view of the further increase in PRA and RRC (Table 9).
Basal RVR in LP rats was almost as high as that induced in
NP by either exogenous Ang II or NE, however, the exogenous
administration of either of the two pressor hormones led to
further rises in RVR and reduced RPF in LP. In both cases, the
FF rose considerably, but it was sufficient to prevent a large fall
in GFR only when exogenous Ang II was administered (80%
increase in FF by Ang II vs. 60% NE). Clearly, each pressor
substance potentiated the endogenous action of the other on
RVR, but Ang II had preeminent effects on renal hemodynam-
ics. In fact, when a-blockade was induced with phentolamine,
RPF and GFR fell proportionately despite a modest (33%) rise
in intrarenal resistance, suggesting that the ultrafiltration coef-
ficient also fell, possibly mediated by increased intrarenal
angiotensin production (as discussed above) [8, 9, 13].
There is evidence that substantiates an important intrarenal
synergistic effect between Ang II and adrenergic activity.
Chronic salt depletion, another dietary manipulation, leads to
increased renal resistance as a consequence of both afferent and
efferent arteriolar vasoconstriction [39]. Under these circum-
stances, increased in afferent resistance appear to be mediated
in approximately equal parts by Ang II and adrenergic stimu-
lation [37], whereas efferent arteriolar resistance is mediated
primarily by Ang II. It has also been shown that inhibition of
Ang II by either saralasin or captopril depresses the vasocon-
strictive response normally observed to 3 Hz renal nerve
stimulation [38]. These results in normal rats, together with
those obtained in the present experiments when LP rats re-
ceived phentolamine, also suggest that Ang II is necessary for
the functional expression of renal nerve activity, or that the two
exhibit parallel synergism, and removal of one alters the func-
tional effects of the other. In addition, the a2 agonist B-HT 933
under some circumstances can mimic the effect of Ang II to
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reduce the ultrafiltration coefficient [40], while the a1 agonist
methoxamine increases the coefficient to greater levels than
those generally achievable with saralasin or converting enzyme
inhibitor [41]. The further reduction in GFR and RPF upon
phentolamine administration to LP is also strongly suggestive of
the local vasoconstrictive effect of Ang II in the presence of a1
and a2 blockade. More recently, it has been clearly shown that
renal aadrenergic and Ang II systems act synergistically to
regulate the glomerular ultrafiltration coefficient [42].
The complete recovery in renal hemodynamics in LP after
acute enalapril infusion confirms our previous results with
chronic captopril therapy [8]. Moreover, it demonstrates that
increased local Ang II formation, as discussed above, may
determine the response to a-adrenoreceptor agonists by the
renal microvasculature in subjects submitted to LP feeding.
It is clear from these experiments that vasoconstriction of the
afferent and efferent arteriole mediated by synergism between
Ang II and a-adrenergic stimulation may be one mechanism by
which LP diets may be beneficial in chronic renal failure since,
under circumstances in which both afferent and efferent resis-
tances are increased, glomerular perfusion and pressure would
fall. This would reduce glomerular damage and reduce the rate
of progression of renal disease.
In summary, intrarenal and systemic interactions between
Ang II and NE play a role in BP and renal hemodynamics
regulation as a result of LP feeding. Increased sympathetic
activity is primarily responsible for the maintenance of BP,
while intrarenal Ang II is principally responsible for the renal
hemodynamic changes induced by LP feeding in rats.
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